Fundraising Fox

Theranostics Health

Rockville, US · Delaware corporation

Biotech

Founders & leadership

LT
Luis T Gutierrez, JrExecutive Officer meaning President and CEO
GD
Glenn D Hoke, PhDPresident & Director

Board

KG
Kevin G QuinnBoard director
JN
James N Cooper, MDExecutive Officer meaning Chair, Board of Directors
BS
Barry S Strauch, MDBoard director
MP
Mitchell P CybulskiBoard director
WD
William D KingBoard director
MD
Michael Dendy YoungBoard director
JB
Joseph Bailes, MDBoard director

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 5 rounds · 2014–2015

▶$225KraisedSep 2015 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin G QuinnDirector
  • James N Cooper, MDExecutive Officer, Director
  • Barry S Strauch, MDDirector
  • Mitchell P CybulskiDirector
  • Luis T Gutierrez, JrExecutive Officer, Director
Offering amount
$225K
Amount sold
$225K
Minimum investment
$25K
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedSep 2015 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James N Cooper, MDExecutive Officer, Director
  • Mitchell P CybulskiDirector
  • Luis T Gutierrez, JrExecutive Officer, Director
  • Barry S Strauch, MDDirector
  • Kevin G QuinnDirector
Offering amount
$150K
Amount sold
$150K
Minimum investment
$25K
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJun 2015 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin G QuinnDirector
  • James N Cooper, MDExecutive Officer, Director
  • Luis T Gutierrez, JrExecutive Officer, Director
  • Barry S Strauch, MDDirector
  • Mitchell P CybulskiDirector
  • William D KingDirector
  • Michael Dendy YoungDirector
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$10K
Sales commissions
$5K
Placement agents
Pickwick Capital Partners, LLC
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
05, 06b
Full filing on SEC EDGAR ↗
▶$855KraisedJun 2015 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William D KingDirector
  • Kevin G QuinnDirector
  • James N Cooper, MDExecutive Officer, Director
  • Joseph Bailes, MDDirector
  • Glenn D Hoke, PhDExecutive Officer, Director
  • Barry S Strauch, MDDirector
  • Michael Dendy YoungDirector
  • Mitchell P CybulskiDirector
Offering amount
$855K
Amount sold
$855K
Minimum investment
$25K
Sales commissions
$17.5K
Placement agents
Pickwick Capital Partners, LLC
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
05, 06b
Full filing on SEC EDGAR ↗
▶$200KraisedApr 2014 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry S Strauch, MDDirector
  • Mitchell CybulskiDirector
  • Joseph Bailes, MDDirector
  • Michael Dendy YoungDirector
  • William D KingDirector
  • Glenn D Hoke, PhDExecutive Officer, Director
  • James N Cooper, MDExecutive Officer, Director
  • Kevin G QuinnDirector
Offering amount
$750K
Amount sold
$200K
Minimum investment
$25K
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
05, 06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Theranostics Health to Launch Breast Cancer Dx in Early 2013, Raise $5M to $10M in Funding | GenomeWebgenomeweb.com · Jun 2012Theranostics Health Signs Research Collaboration Agreement - BioSpacebiospace.com · May 2008

Frequently asked questions

How much funding has Theranostics Health raised?
Theranostics Health has disclosed $2.9M raised across 5 rounds.
Where is Theranostics Health headquartered?
Theranostics Health is headquartered in Rockville, US.